References
- Mishell Jr MS, Droegemueller W, Herbst AL. Comprehensive gynecology. 3rd ed. St. Louis: Mosby; 1997.
- Crosbie EJ, Zwahlen M, Kitchener HC, et al. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010;19:3119–30.
- Ziel HK. Estrogen's role in endometrial cancer. Obstet Gynecol 1982;60:509–15.
- Key TJ, Pike MC. The dose-effect relationship between ‘unopposed’ oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205–12.
- Judd HL, Davidson BJ, Frumar AM, et al. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 1980;136:859–71.
- Gambrell RD, Jr., Bagnell CA, Greenblatt RB. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review. Am J Obstet Gynecol 1983; 146:696–707.
- Lin CS XZ, Deng CH, Ning H, et al. Defining adipose tissue-derived stem cells in tissue and in culture. 2010; Available from: http://europepmc.org/abstract/MED/20376787.
- Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005;69(Suppl. 3):4–10.
- Sivridis E. Angiogenesis and endometrial cancer. Anticancer Res 2001;21(6B):4383–8.
- Razmkhah M, Jaberipour M, Erfani N, et al. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response? Cell Immunol. 2011; 266:116–22.
- Prantl L, Muehlberg F, Navone NM, et al. Adipose tissue-derived stem cells promote prostate tumor growth. Prostate 2010;70:1709–15.
- Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev 2006;5:91–116.
- Nishida M. The Ishikawa cells from birth to the present. Human Cell 2002;15:104–17.
- Wadden TA, Butryn ML, Sarwer DB, et al. Comparison of psychosocial status in treatment-seeking women with class III vs. class I-II obesity. Surg Obesity Rel Dis 2006;2:138–45.
- Hong SJ, Traktuev DO, March KL. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Current Opin Organ Transplant 2010;15:86–91.
- Linkov F, Gu Y, Arslan AA, et al. Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur Cytokine Netw 2009;20:21–6.
- Gu Y, Zeleniuch-Jacquotte A, Linkov F, et al. Reproducibility of serum cytokines and growth factors. Cytokine 2009;45:44–9.
- Arslan AA, Gu Y, Zeleniuch-Jacquotte A, et al. Reproducibility of serum pituitary hormones in women. Cancer Epidemiol Biomarkers Prev 2008;17:1880–3.
- Leibel RL, Edens NK, Fried SK. Physiologic basis for the control of body fat distribution in humans. Annu Rev Nutr 1989;9:417–43.
- Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991;14:1132–43.
- Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761–811.
- Nakamura K, Hongo A, Kodama J, et al. Fat accumulation in adipose tissues as a risk factor for the development of endometrial cancer. Oncol Rep 2011;26:65–71.